ResMed Inc (RMD)

Gross profit margin

		Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019
Gross profit (ttm)	US$ in thousands	2,655,302	2,557,162	2,482,133	2,414,914	2,355,664	2,260,783	2,134,228	2,058,831	2,024,310	1,992,501	1,948,562	1,906,727	1,839,099	1,797,775	1,800,179	1,764,826	1,717,784	1,670,843	1,602,151	1,549,553
Revenue (ttm)	US$ in thousands	4,681,240	4,528,920	4,442,900	4,314,610	4,171,410	4,064,591	3,819,396	3,688,938	3,645,890	3,606,884	3,513,684	3,419,445	3,265,514	3,144,973	3,128,793	3,045,837	2,957,056	2,891,676	2,784,449	2,699,392
Gross profit margin		56.72%	56.46%	55.87%	55.97%	56.47%	55.62%	55.88%	55.81%	55.52%	55.24%	55.46%	55.76%	56.32%	57.16%	57.54%	57.94%	58.09%	57.78%	57.54%	57.40%

June 30, 2024 calculation

Gross profit margin = Gross profit (ttm) ÷ Revenue (ttm)
= $2,655,302K ÷ $4,681,240K
= 56.72%

ResMed Inc's gross profit margin has shown relatively stable performance over the past five years, ranging from a high of 58.09% to a low of 55.24%. The company has consistently maintained a gross profit margin above 55%, indicating strong cost control and efficient operations in generating profits from sales. The overall trend suggests that ResMed has been able to effectively manage its cost of goods sold relative to its revenue, leading to consistent and healthy margins. This stability in gross profit margin is a positive signal of the company's operational efficiency and ability to maintain profitability over time.